Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 20/02/2008

    ZRM and Naturin develop innovative biomembranes

    The Centre for Regenerative Biology and Medicine ZRM in Tübingen has joined forces with Naturin GmbH based in Weinheim. The partners plan to develop new carrier materials on the basis of collagen which improve cell cultures and medical implants.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/zrm-and-naturin-develop-innovative-biomembranes
  • Press release - 08/01/2009 The figure shows two photos, both of them have a dark red background and light red spots; the right sides of the two photos is twice as light as the left side.<br />

    ILM – Bioactive interfaces

    It is particularly important to consider the biocompatibility of material interfaces. For example, implant materials with a surface composition that favours cell growth have a decisive advantage. However there are other cases where biophobic material characteristics might be more suitable. For example, specifically modifying the surface of surgical metals might prevent pathogens from attaching and could also make the cleaning and deactivation of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-bioactive-interfaces
  • Article - 06/12/2010 An Asian in a dark suit presenting data.

    Bioplastics – materials that have the potential to be used in medical technology

    At the recent International Symposium on Biopolymers ISBP in Stuttgart scientists discussed the use of biobased plastics for applications in the field of medical technology. The majority of strategies presented at the symposium will only be ready for market in a few years time. However they give an idea as to why bioplastics are likely to be applied to a greater extent in the field of medical technology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bioplastics-materials-that-have-the-potential-to-be-used-in-medical-technology
  • Press release - 25/01/2010 10566_de.jpg

    Amedrix GmbH - New investment paves the way for own production operations

    The High-Tech Gründerfonds (HTGF) and Life Science Fonds Esslingen are jointly investing a total of 700,000 EUR in Amedrix GmbH, which was founded in January 2009. The Esslingen-based company develops innovative, acellular medical products based on animal collagen for wound regeneration and the reconstruction of degenerated soft tissue, for example. The new investment means that necessary steps can be taken to gain approval for first medical…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/amedrix-gmbh-new-investment-paves-the-way-for-own-production-operations
  • Article - 02/05/2016 hv_PhaZd1__C_WT.jpg

    Biopolymers – raw materials for innovative medical products

    Polyhydroxyalkanoates (PHA) are biodegradable biopolymers that are becoming increasingly important. Bioplastics are now used not only in everyday objects such as plastic bags and yogurt pots but also increasingly in the field of medicine, which is why intensive research into medical devices made from biodegradable polymers such as PHA has been going on for quite some time.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biopolymers-raw-materials-for-innovative-medical-products
  • Article - 26/03/2014 21246_de.jpg

    CeloNova is taking off

    CeloNova BioSciences is a global medical device company whose core technology is currently mainly used for interventional cardiology (stents) and tumour embolisation (selective occlusion of tumour arteries) products. The company has been expanding since 2010. CeloNova products are currently available in 52 countries and there are plans to place them on the Asian market in 2014 and further increase company turnover.

    https://www.gesundheitsindustrie-bw.de/en/article/news/celonova-is-taking-off
  • Article - 18/04/2011 09570_de.jpg

    Can tissue be glued together in a non-invasive way?

    At present, the use of substances to glue tissue together is only an idea, but it might eventually mean that surgeons will no longer need to use a needle and thread. The cellular and molecular biologist Rainer Wittig from the Ulm-based ILM hopes to develop such substances using a photochemical process. He is also planning to test substances that not only adhere to tissue but which will also be able to initiate the wound healing process.

    https://www.gesundheitsindustrie-bw.de/en/article/news/can-tissue-be-glued-together-in-a-non-invasive-way
  • Press release - 04/07/2018 The collagen membrane „Collagen Cell Carrier“ is thin, elastic, yet robust and biocompatible.

    Phase-I-trial approved for novel stem cell therapy for patients with ischemic cardiomyopathy

    Viscofan BioEngineering, the biomedical business unit of the world market leader for collagenous sausage casings Viscofan announced today that the Spanish Agency for Medicines (AEMPS) has given green light to carry out a clinical phase-I-trial with Viscofan BioEngineering’s first product for regenerative medicine. The novel therapy consisting of stem cells on a collagenous carrier membrane can now be tested on ten patients suffering from severe…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/phase-i-trial-approved-for-novel-stem-cell-therapy-for-patients-with-ischemic-cardiomyopathy
  • Article - 30/01/2012 16256_de.jpg

    Silicone application in medical technology

    Silicone is flexible, biocompatible and heat-resistant, characteristics that make organosilicone compounds ideal for a wide range of applications in medical technology. Up until now, the broad application of such compounds has been hampered chiefly by the high surface friction of silicone. The Reutlingen-based company Silcos GmbH has developed special methods for the treatment of surfaces that considerably improve the compound's range of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/silicone-application-in-medical-technology
  • Article - 22/06/2015 The schematic shows how the blood vessel-containing printed tissue will look like.

    3D bioprinting: replicating the shape of bone parts

    Prof. Dr. Günter Finkenzeller, head of the Research and Tissue Engineering Laboratory in the Department of Plastic and Hand Surgery at the Freiburg University Medical Centre, and Dr. Peter Koltay from the Department of Microsystems Engineering (IMTEK) at the University of Freiburg, are being given German Research Foundation (DFG) funds for a period of three years to develop a 3D printing technique for functional bone tissue containing blood…

    https://www.gesundheitsindustrie-bw.de/en/article/news/3d-bioprinting-replicating-the-shape-of-bone-parts
  • Article - 17/11/2015 Electron microscope image of crystalline precipitates secreted by Halomonas bacteria. The precipitates are stained blue.

    Novel hydrogels as functional materials

    In the ”NanoBioMater”project house, researchers from the University of Stuttgart are working to develop novel hydrogels with integrated biocompatible scaffold structures. Their aim is to make the materials suitable for producing innovative components for environmental and food analytics as well as medical applications. The hydrogels could potentially be used in diagnostic biosensors and the controlled release of medical compounds.

    https://www.gesundheitsindustrie-bw.de/en/article/news/novel-hydrogels-as-functional-materials
  • Press release - 21/03/2011 Protection: The microscope photos show that much fewer bacteria colonise coated (photo on the left, fewer green spots) rather than uncoated sections of implants (a larger number of green spots).<br />

    Polymer brushes with mini proteins protect implants

    Patients who have had surgical implants are at risk of developing serious complications due to bacterial infections. This affects around two to six per cent of patients with implants. Scientists from the KIT Institute of Functional Interfaces (IFG) have now succeeded in developing a protective layer that prevents bacteria from adhering to implants and creating dangerous biofilms that can lead to serious infections. The protective layer has proven…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/polymer-brushes-with-mini-proteins-protect-implants
  • Article - 05/05/2014 21313_de.jpg

    Michael Doser brings together biomedicine and textile research

    Textile products used for the treatment of wounds are increasingly being coupled with bioactive functions. A growing number of biocompatible and absorbable high-tech materials are used on and in the human body for therapy, diagnosis and measurements. Michael Doser, Director of Medical Engineering/Biomedical Process Engineering at the ITV Denkendorf, is working on innovative wound management products and processes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-doser-brings-together-biomedicine-and-textile-research
  • Article - 12/06/2010 Technician in front of a microscope, looking at the results on a computer screen.<br />

    Reliable evidence of efficacy using skin models and assays

    In the molecular biology laboratory at the Albstadt-Sigmaringen University of Applied Sciences a team led by Prof. Dr. Jörg Bergemann is developing and optimising assays that enable the quantitative determination of DNA damage and the investigation of repair mechanisms. The researchers exclusively use in vitro test systems. Using tissue engineering methods the researchers are developing a skin model for pharmacological efficacy and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/reliable-evidence-of-efficacy-using-skin-models-and-assays
  • Article - 01/09/2016 Woman holding a small round piece of fabric.

    Tailor-made biotech fibres for improved wound dressings

    Scientists have developed a biotechnological process to produce bacterial alginate. The alginate quality is highly reproducible, making it suitable for the production of fibre-based medicinal products such as wound dressings.

    https://www.gesundheitsindustrie-bw.de/en/article/news/made-to-measure-biotech-fibres
  • Article - 14/04/2014 Small glass vial filled with whitish hydrogel and turned upside down. The hydrogel's consistency makes it adhere to the glass and prevents it from flowing out of the vial.

    Small, round, versatile: cyclic dipeptides in hydrogels

    Researchers from the University of Tübingen have discovered a new type of hydrogelators: cyclic peptides consisting of amino acid building blocks that are also found in the human body. Preliminary work has shown that these hydrogels are excellently suited as carriers for medical substances. In addition, mechanically damaged hydrogels have excellent self-healing capacity and are therefore suitable for injection-based drug delivery.

    https://www.gesundheitsindustrie-bw.de/en/article/news/small-round-versatile-cyclic-dipeptides-in-hydrogels
  • Article - 17/09/2012 18052_de.jpg

    Alexander Wittemann: polymeric nanostructures as carriers of biomolecules

    Vesicles form naturally in cells and can do many things including transporting pharmaceutically active substances to tumours. However natural vesicles only have a short lifespan which can lead to the premature release of the drug enclosed within them. Alexander Wittemann a chemist at Konstanz University has successfully developed artificial biocompatible polymer vesicles with a much longer lifespan.

    https://www.gesundheitsindustrie-bw.de/en/article/news/alexander-wittemann-polymeric-nanostructures-as-carriers-of-biomolecules
  • Article - 04/07/2011 14640_de.jpg

    The adhesion of cells to the endothelium and to artificial surfaces

    Professor Stefan W. Schneider from the Mannheim Medical Faculty is investigating the function of the vascular endothelium and its interaction with blood and tumour cells using microfluidics methods that enable him to measure the adhesion of cells to the walls of blood vessels under physiological flow conditions. As part of an interdisciplinary project, he is investigating the characteristics of wafer-thin surfaces covered with living cells, which…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-adhesion-of-cells-to-the-endothelium-and-to-artificial-surfaces
  • Press release - 11/10/2012 18383_de.jpg

    Novalung GmbH receives EU grant for the development of a cell-coated artificial lung

    The AmbuLung (Ambulatory Bioartificial Lung) project is a milestone in the history of artificial organs and is being subsidized by the EU with a total of 5.6 Million Euros - 3 Million Euros will go to Novalung as the Coordinator of the European development consortium. The joint developmental goal is the AmbuLung, which will allow patients to remain awake, mobile and active despite lung failure. The core innovation within the framework of the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novalung-gmbh-receives-eu-grant-for-the-development-of-a-cell-coated-artificial-lung
  • Press release - 13/03/2011 13874_de.jpg

    Vascular stent that dissolves on its own

    The first ever implant in Germany of a bioresorbable, drug-coated stent in a cardiac patient has been carried out by physicians from the University of Heidelberg. In contrast to traditional metal stents, which remain permanently in the patients’ body, the innovative implant dissolves around two years after the procedure is carried out.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vascular-stent-that-dissolves-on-its-own
  • Article - 22/11/2016 Eine Maschine im Biomechanik-Labor, die Druck und Bewegung erzeugt.

    Research on the durability and longevity of artificial joints

    In Germany alone, several hundred thousand patients are given an artificial hip, knee or shoulder joint every year. Prof. Dr. Jan Philippe Kretzer and his team of researchers in the Laboratory of Biomechanics and Implant Research at the University Hospital in Heidelberg are studying what limits the longevity of implants and how durability can be improved.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-on-the-durability-and-longevity-of-artificial-joints
  • Dossier - 04/07/2011 The cement-free Metha® Short Hip Stem prosthesis with Plasmapore® µ-CaP coating of the entire proximal surface supports rapid secondary fixation. µ-CaP is applied on the microporous titanium Plasmapore® surface. It has an osteoconductive effect and accelerates contact between the bone and the prosthesis stem.

    Implants of the future: bioactive, corrosion-resistant and antibacterial

    People’s life expectancy is increasing due to constantly improving medical treatment. One result of this is the greater wear of joints, which then need to be replaced with implants. Increased life expectancy means that the implants remain in the body for much longer and therefore need to be longer lasting. The revision rate of implant materials used in clinical practice is still as much as 10 per cent, particularly in the case of hip and knee…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/implants-of-the-future-bioactive-corrosion-resistant-and-antibacterial
  • Press release - 24/11/2008

    Schölly Fibre Optics in Denzlingen – at the limit of production capacities

    Schölly Fiberoptic GmbH based in the city of Denzlingen in the south of Germany has experienced rapid growth over the last few years with its endoscopic solutions. Over the last five years the company has doubled its revenues to 44 million euros per year.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/schoelly-fibre-optics-in-denzlingen-at-the-limit-of-production-capacities
  • Press release - 16/07/2012 17688_de.jpg

    Winners of the "Science2Start" ideas competition honoured

    BioRegio STERN Management GmbH honoured the three winners of the regional "Science2Start" ideas competition last Thursday evening. The award ceremony was part of the traditional summer soirée given by BioRegio STERN Management GmbH in collaboration with TTR Technologieparks Tübingen-Reutlingen GmbH, the Verein zur Förderung der Biotechnologie und der Medizintechnik e.V. (Society for the Promotion of Biotechnology and Medical Technology)…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/winners-of-the-science2start-ideas-competition-honoured
  • Article - 18/07/2011 The photo shows an X-ray image of a jaw from the front; numerous screws with artificial teeth attached to them are shown in white.<br />

    Titanium screws and stem cells for dental implants

    How are we supposed to chew and smile when the tooth fairy comes to fetch our second set of teeth? When it’s difficult to tell the difference between modern tooth implants and real teeth in both technical and aesthetical terms, people who lose their teeth due to accidents or age very quickly regain their smile. However, there needs to be enough bone to hold and support the implant. Prof. Dr. Dr. Ralf Gutwald and his team in the Department of Oral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/titanium-screws-and-stem-cells-for-dental-implants

Page 1 / 2

sb_search.block.search_result.other.pages

  • 1
  • 2
  • eine Seite zurück
  • Extend search to all portals
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2019 BIOPRO Baden-Württemberg
Website address: https://www.gesundheitsindustrie-bw.de/en/search